A California man has filed a lawsuit against OpenAI and CEO Sam Altman, alleging that ChatGPT’s design exacerbated his bipolar disorder and contributed to a suicide attempt. Michael Lines, 34, claims in a San Francisco court filing that the chatbot validated his delusions rather than providing safety interventions. This case highlights growing legal scrutiny regarding … Read more
The British government has signaled a potential intervention in the $110 billion merger between Paramount Skydance Corp and Warner Bros. Discovery, citing concerns over media plurality and the regulation of on-demand streaming services. According to a statement from the UK government, Culture Minister Lisa Nandy has set a July 6 deadline for the companies to … Read more
The U.S. Food and Drug Administration (FDA) has officially accepted for review Sandoz’s applications for two generic versions of tirzepatide, the active ingredient in Eli Lilly’s popular weight-loss and diabetes treatments. This regulatory step marks a significant move toward potential market competition for Mounjaro and Zepbound ahead of the expiration of Eli Lilly’s U.S. patents … Read more
Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more
SpaceX plans to begin construction next month on an eight-mile natural gas pipeline, dubbed “Starpipe,” to supply its Starbase launch site in Texas, according to county filings reviewed by Reuters. The infrastructure project is designed to facilitate a higher cadence of launches for the Starship rocket, moving away from a reliance on tanker trucks for … Read more
Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more
Western Europe is grappling with a severe heatwave that has shattered historical temperature records, resulting in dozens of deaths, widespread power grid disruptions, and significant agricultural losses. Authorities across France, the United Kingdom, Spain, and Italy report that extreme conditions—driven by a rare “Omega block” weather pattern—have forced school closures, altered public infrastructure operations, and … Read more
The U.S. government has begun shipping stockpiled doses of an experimental antibody drug, MBP134, from Mapp Biopharmaceutical to the Democratic Republic of Congo to combat a widening Bundibugyo Ebola outbreak. According to the U.S. Department of Health and Human Services, this shift in policy marks the first time Washington has released the treatment for clinical … Read more
The state of California has filed a lawsuit against the U.S. Environmental Protection Agency (EPA) to block an attempt to repeal long-standing vehicle emissions waivers. The EPA recently sent these waivers to Congress for potential revocation under the Congressional Review Act, a move California Attorney General Rob Bonta describes as an illegal effort to undermine … Read more
Claude Guillemot, a co-founder of the global video-game publisher Ubisoft and chairman of Guillemot Corp, died in a plane crash on Friday near La Baule, France. He was 69. According to reports from Ouest-France, the twin-engine Cessna 421 carrying two passengers crashed in the coastal resort town, which was preparing to host an air show. … Read more